JP2017533263A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017533263A5 JP2017533263A5 JP2017540961A JP2017540961A JP2017533263A5 JP 2017533263 A5 JP2017533263 A5 JP 2017533263A5 JP 2017540961 A JP2017540961 A JP 2017540961A JP 2017540961 A JP2017540961 A JP 2017540961A JP 2017533263 A5 JP2017533263 A5 JP 2017533263A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- diyl
- substituted
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 24
- 125000000217 alkyl group Chemical group 0.000 claims 17
- -1 piperazine-1,4-diyl Chemical group 0.000 claims 13
- 125000001424 substituent group Chemical group 0.000 claims 12
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 7
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 125000003107 substituted aryl group Chemical group 0.000 claims 5
- 208000023275 Autoimmune disease Diseases 0.000 claims 4
- 208000035473 Communicable disease Diseases 0.000 claims 4
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 4
- 125000003282 alkyl amino group Chemical group 0.000 claims 4
- 208000037976 chronic inflammation Diseases 0.000 claims 4
- 208000037893 chronic inflammatory disorder Diseases 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Natural products C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 3
- 125000001475 halogen functional group Chemical group 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 3
- 241001120493 Arene Species 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 206010022000 influenza Diseases 0.000 claims 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000004103 aminoalkyl group Chemical group 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462068322P | 2014-10-24 | 2014-10-24 | |
| US62/068,322 | 2014-10-24 | ||
| US201562101164P | 2015-01-08 | 2015-01-08 | |
| US62/101,164 | 2015-01-08 | ||
| PCT/US2015/021417 WO2016064445A1 (en) | 2014-10-24 | 2015-03-19 | Lanthionine synthetase c-like 2-based therapeutics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019046867A Division JP6806829B2 (ja) | 2014-10-24 | 2019-03-14 | ランチオニンシンテターゼｃ様２系治療薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017533263A JP2017533263A (ja) | 2017-11-09 |
| JP2017533263A5 true JP2017533263A5 (enExample) | 2018-04-26 |
| JP6499306B2 JP6499306B2 (ja) | 2019-04-10 |
Family
ID=52811239
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017540961A Active JP6499306B2 (ja) | 2014-10-24 | 2015-03-19 | ランチオニンシンテターゼｃ様２系治療薬 |
| JP2019046867A Active JP6806829B2 (ja) | 2014-10-24 | 2019-03-14 | ランチオニンシンテターゼｃ様２系治療薬 |
| JP2020201503A Pending JP2021073170A (ja) | 2014-10-24 | 2020-12-04 | ランチオニンシンテターゼｃ様２系治療薬 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019046867A Active JP6806829B2 (ja) | 2014-10-24 | 2019-03-14 | ランチオニンシンテターゼｃ様２系治療薬 |
| JP2020201503A Pending JP2021073170A (ja) | 2014-10-24 | 2020-12-04 | ランチオニンシンテターゼｃ様２系治療薬 |
Country Status (21)
| Country | Link |
|---|---|
| US (9) | US9556146B2 (enExample) |
| EP (2) | EP3209655B1 (enExample) |
| JP (3) | JP6499306B2 (enExample) |
| KR (3) | KR20200087273A (enExample) |
| CN (2) | CN111592508A (enExample) |
| AU (3) | AU2015337091B2 (enExample) |
| BR (1) | BR112017008416B1 (enExample) |
| CA (1) | CA2965472C (enExample) |
| DK (1) | DK3209655T3 (enExample) |
| ES (1) | ES2822987T3 (enExample) |
| HR (1) | HRP20201416T1 (enExample) |
| HU (1) | HUE051299T2 (enExample) |
| IL (2) | IL252630B (enExample) |
| LT (1) | LT3209655T (enExample) |
| NZ (1) | NZ732213A (enExample) |
| PL (1) | PL3209655T3 (enExample) |
| PT (1) | PT3209655T (enExample) |
| RS (1) | RS61013B1 (enExample) |
| RU (3) | RU2688677C2 (enExample) |
| SI (1) | SI3209655T1 (enExample) |
| WO (1) | WO2016064445A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6499306B2 (ja) * | 2014-10-24 | 2019-04-10 | ランドス バイオファーマ インコーポレイテッド | ランチオニンシンテターゼｃ様２系治療薬 |
| WO2019050890A1 (en) | 2017-09-05 | 2019-03-14 | President And Fellows Of Harvard College | METHODS AND COMPOSITIONS FOR THE TREATMENT OF TUBERCULOSIS |
| WO2019099426A1 (en) * | 2017-11-17 | 2019-05-23 | Icahn School Of Medicine At Mount Sinai | Influenza virus inhibitor targeting nucleoprotein |
| JP2021503936A (ja) | 2017-11-30 | 2021-02-15 | ランドス バイオファーマ インコーポレイテッド | ランチオニンｃ様タンパク質２リガンドによる治療及びそれにより調製された細胞 |
| CN113874015B (zh) | 2018-12-21 | 2024-05-24 | 细胞基因公司 | Ripk2的噻吩并吡啶抑制剂 |
| PL3927427T3 (pl) * | 2019-12-20 | 2024-06-10 | Nimmune Biopharma, Inc. | Ligandy białka 2 podobnego do lantioniny c, komórki otrzymane z ich użyciem i terapie z ich wykorzystaniem |
| US12234578B2 (en) | 2020-01-29 | 2025-02-25 | Wisconsin Alumni Research Foundation | Tannin composite fibers |
| US20230107927A1 (en) | 2020-02-28 | 2023-04-06 | First Wave Bio, Inc. | Methods of treating iatrogenic autoimmune colitis |
| WO2022057928A1 (zh) | 2020-09-18 | 2022-03-24 | 上海医药集团股份有限公司 | 一种羰基杂环类化合物及其应用 |
| WO2022057932A1 (zh) * | 2020-09-18 | 2022-03-24 | 上海医药集团股份有限公司 | 一种羰基杂环类化合物及其应用 |
| WO2022087146A1 (en) | 2020-10-22 | 2022-04-28 | Landos Biopharma, Inc. | Lancl ligands |
| WO2022098644A1 (en) | 2020-11-03 | 2022-05-12 | Landos Biopharma, Inc. | Crystalline forms of piperazine-1,4-diylbis((6-(1h-benzoi[d]imidazo-2-yl)pyridin-2yl)methanone) as lancl2 modulators |
| WO2022108997A2 (en) | 2020-11-19 | 2022-05-27 | Landos Biopharma, Inc. | Compounds, compositions, and methods for treating inflammatory or immune-mediated conditions of surface tissues |
| CN116670137B (zh) * | 2020-12-15 | 2025-06-06 | 康百达（四川）生物医药科技有限公司 | 吡啶衍生物及其在医药上的应用 |
| CN113908256B (zh) * | 2021-11-26 | 2023-05-26 | 中国农业科学院兰州兽医研究所 | Lancl1蛋白在制备抗病毒药物中的应用 |
| WO2024155555A1 (en) * | 2023-01-16 | 2024-07-25 | Nimml Institute | Neuroprotective compounds for therapeutic use |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0282643A3 (en) | 1986-11-22 | 1990-08-22 | The Green Cross Corporation | Use of pharmaceutical compositions comprising cyclohexane derivatives in the treatment or prevention of peptic ulcers |
| CZ196297A3 (cs) * | 1994-12-23 | 1998-01-14 | Smithkline Beecham Corporation | 4,4-(Disubstituované)cyklohexan-1-onové monomery a odvozené sloučeniny, farmaceutický prostředek a použití |
| US5856326A (en) | 1995-03-29 | 1999-01-05 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| IL117580A0 (en) | 1995-03-29 | 1996-07-23 | Merck & Co Inc | Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them |
| US5633388A (en) | 1996-03-29 | 1997-05-27 | Viropharma Incorporated | Compounds, compositions and methods for treatment of hepatitis C |
| JP4382880B2 (ja) * | 1996-10-11 | 2009-12-16 | 興和株式会社 | 新規なジアミド化合物及びこれを含有する医薬 |
| KR20010033528A (ko) * | 1997-12-24 | 2001-04-25 | 헨리 필리 파르, 올리비에 보우언 | 골다공증의 치료를 위한 ａ.ｏ.에 유용한 인돌 유도체 |
| JP2002501898A (ja) | 1998-02-02 | 2002-01-22 | メルク エンド カムパニー インコーポレーテッド | ケモカイン受容体活性の環状アミン調節剤 |
| GB9914825D0 (en) * | 1999-06-24 | 1999-08-25 | Smithkline Beecham Spa | Novel compounds |
| JP2001247550A (ja) * | 1999-12-27 | 2001-09-11 | Japan Tobacco Inc | 縮合環化合物及びその医薬用途 |
| CA2401489A1 (en) * | 2000-03-02 | 2001-09-07 | Ichiro Miki | Oxygen-containing heterocyclic compounds |
| US20090124690A1 (en) | 2000-04-03 | 2009-05-14 | Alberte Randall S | Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins |
| DK1317451T3 (da) | 2000-09-15 | 2006-12-18 | Anormed Inc | Kemokinreceptorbindende heterocykliske forbindelser |
| RU2297413C2 (ru) | 2000-09-15 | 2007-04-20 | Анормед, Инк. | Гетероциклические соединения, моделирующие активность хемокинового рецептора, их применение и содержащая их фармацевтическая композиция |
| SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| AR040335A1 (es) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto |
| EP1679069A4 (en) | 2003-10-21 | 2009-05-13 | Dainippon Sumitomo Pharma Co | NEW PIPERIDINE DERIVATIVE |
| WO2005082905A1 (ja) * | 2004-02-26 | 2005-09-09 | Kyowa Hakko Kogyo Co., Ltd. | 二環性複素環化合物 |
| US7674907B2 (en) | 2004-07-23 | 2010-03-09 | Amgen Inc. | Furanopyridine derivatives and methods of use |
| US20060093580A1 (en) | 2004-11-04 | 2006-05-04 | Makio Iwashima | Tolerogenic vaccine and method |
| TW200628463A (en) | 2004-11-10 | 2006-08-16 | Synta Pharmaceuticals Corp | Heteroaryl compounds |
| KR101099303B1 (ko) | 2005-01-28 | 2011-12-26 | 주식회사 대웅제약 | 신규한 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물 |
| GB0508314D0 (en) * | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
| CN100434419C (zh) | 2005-06-03 | 2008-11-19 | 中国人民解放军军事医学科学院毒物药物研究所 | 单环多取代饱和环已酮类化合物及其制备方法和用途 |
| US7754724B2 (en) | 2005-06-30 | 2010-07-13 | Dow Agrosciences Llc | N-substituted piperazines |
| ES2372701T3 (es) | 2005-07-22 | 2012-01-25 | Shionogi & Co., Ltd. | Derivado de indol que tiene actividad antagonista del receptor de pgd2. |
| EP1911759A4 (en) | 2005-07-22 | 2010-07-21 | Shionogi & Co | AZAINDOL DERIVATIVE ANTAGONISTIC EFFECT ON PGD2 RECEPTOR |
| ES2397275T3 (es) | 2005-08-04 | 2013-03-05 | Sirtris Pharmaceuticals, Inc. | Derivados de imidazopiridina como agentes moduladores de la sirtuína |
| EP1932839A4 (en) | 2005-09-06 | 2014-09-10 | Shionogi & Co | INDOLECARBOXYLATE ACID DERIVATIVE HAVING ANTAGONIST EFFECT OF THE PGD2 RECEPTOR |
| EP1939175B1 (en) | 2005-09-27 | 2017-03-01 | Shionogi&Co., Ltd. | Sulfonamide derivative having pgd2 receptor antagonistic activity |
| AR055669A1 (es) | 2005-10-03 | 2007-08-29 | Astrazeneca Ab | Derivados de 3h - imidazo[4, 5 -b]piridina como inhibidores selectivos de gsk3, metodos e internediarios para su preparacion, composiciones farmaceuticas que los contienen y su uso para la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y mentales. |
| US20070203236A1 (en) | 2006-01-11 | 2007-08-30 | Smith Jeffrey W | Novel antagonists of the human fatty acid synthase thioesterase |
| US8367727B2 (en) | 2006-02-08 | 2013-02-05 | Virginia Tech Intellectual Properties, Inc. | Method of using abscisic acid to treat diseases and disorders |
| US7741367B2 (en) | 2006-02-08 | 2010-06-22 | Virginia Tech Intellectual Properties, Inc. | Method of using abscisic acid to treat diseases and disorders |
| JP2008056615A (ja) | 2006-08-31 | 2008-03-13 | Fujifilm Corp | ビニルエチニルアリールカルボン酸類、その製造方法及びそれを用いた熱架橋性化合物の製造方法 |
| EP2091566A4 (en) | 2006-11-24 | 2011-07-06 | Waratah Pharmaceuticals Inc | COMBINATION THERAPIES AGAINST ALZHEIMER DISEASE AND SIMILAR ILLNESSES |
| JP2010513519A (ja) | 2006-12-22 | 2010-04-30 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | キナーゼインヒビター活性を有するある種のピラゾリン誘導体 |
| WO2008092006A2 (en) | 2007-01-24 | 2008-07-31 | Cernofina, Llc | Antimicrobial compositions |
| MY146643A (en) | 2007-07-30 | 2012-09-14 | Dae Woong Pharma | Novel benzoimidazole derivatives and pharmaceutical composition comprising the same |
| JP2011505341A (ja) | 2007-11-21 | 2011-02-24 | デコード ジェネティクス イーエイチエフ | 炎症性、心血管およびｃｎｓ障害を治療するビアリールｐｄｅ４抑制剤 |
| WO2009067621A1 (en) | 2007-11-21 | 2009-05-28 | Decode Genetics Ehf | Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| TWI471322B (zh) | 2008-10-27 | 2015-02-01 | Mitsubishi Tanabe Pharma Corp | 新穎醯胺衍生物及其作為醫藥之用途 |
| US8541424B2 (en) | 2008-12-23 | 2013-09-24 | Abbott Laboratories | Anti-viral compounds |
| CA2647900C (en) | 2008-12-23 | 2017-05-16 | National Research Council Of Canada | Inhibitors of a 9-cis-epoxycarotenoid dioxygenase |
| RU2505539C2 (ru) | 2008-12-23 | 2014-01-27 | Эбботт Лэборетриз | Антивирусные соединения |
| NZ595432A (en) | 2009-04-17 | 2013-12-20 | Janssen Pharmaceutica Nv | 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2 |
| US9062564B2 (en) * | 2009-07-31 | 2015-06-23 | General Electric Company | Solvent based slurry compositions for making environmental barrier coatings and environmental barrier coatings comprising the same |
| CN102656141B (zh) * | 2009-10-13 | 2016-04-06 | 利亘制药公司 | 模拟造血生长因子的小分子化合物及其用途 |
| DE102009057167A1 (de) | 2009-12-05 | 2011-06-09 | Merck Patent Gmbh | Elektronische Vorrichtung enthaltend Metallkomplexe |
| JP2011246461A (ja) | 2010-04-27 | 2011-12-08 | Mitsubishi Tanabe Pharma Corp | 新規アミド誘導体を含有する医薬組成物 |
| US9101573B2 (en) * | 2010-05-04 | 2015-08-11 | Virginia Tech Intellectual Properties, Inc. | Lanthionine synthetase component C-like proteins as molecular targets for preventing and treating diseases and disorders |
| US8993624B2 (en) | 2010-05-26 | 2015-03-31 | Virginia Tech Intellectual Properties, Inc. | Method of preventing and treating inflammatory diseases and disorders with abscisic acid |
| TW201211027A (en) | 2010-06-09 | 2012-03-16 | Janssen Pharmaceutica Nv | Cyclohexyl-azetidinyl antagonists of CCR2 |
| KR101743280B1 (ko) | 2010-06-17 | 2017-06-02 | 얀센 파마슈티카 엔.브이. | Ccr2의 사이클로헥실-아제티디닐 길항제 |
| CA2806341C (en) | 2010-07-29 | 2020-03-24 | Rigel Pharmaceuticals, Inc. | Ampk-activating heterocyclic compounds and methods for using the same |
| KR20120035285A (ko) | 2010-10-05 | 2012-04-16 | 에스케이이노베이션 주식회사 | 셀룰로오스아세테이트 필름 |
| CN105658628A (zh) | 2011-12-30 | 2016-06-08 | 北京赛林泰医药技术有限公司 | 新型芳基乙烯衍生物及其在选择性雌激素受体调节剂中的应用 |
| CN103709115A (zh) | 2012-10-09 | 2014-04-09 | 山东亨利医药科技有限责任公司 | 截短侧耳素类抗生素衍生物 |
| JP6441888B2 (ja) | 2013-03-13 | 2018-12-19 | インフラマトリー・レスポンス・リサーチ・インコーポレイテッド | 自己免疫性障害の処置におけるレボセチリジン及びモンテルカストの使用 |
| WO2015048547A2 (en) | 2013-09-26 | 2015-04-02 | Rigel Pharmaceuticals, Inc. | Methods for using and biomarkers for ampk-activating compounds |
| JP6150701B2 (ja) | 2013-09-30 | 2017-06-21 | キヤノン株式会社 | 電子写真感光体、プロセスカートリッジおよび電子写真装置 |
| JP6499306B2 (ja) * | 2014-10-24 | 2019-04-10 | ランドス バイオファーマ インコーポレイテッド | ランチオニンシンテターゼｃ様２系治療薬 |
-
2015
- 2015-03-19 JP JP2017540961A patent/JP6499306B2/ja active Active
- 2015-03-19 NZ NZ732213A patent/NZ732213A/en unknown
- 2015-03-19 PL PL15714352T patent/PL3209655T3/pl unknown
- 2015-03-19 HU HUE15714352A patent/HUE051299T2/hu unknown
- 2015-03-19 CN CN202010405608.8A patent/CN111592508A/zh active Pending
- 2015-03-19 RU RU2017117562A patent/RU2688677C2/ru active
- 2015-03-19 CA CA2965472A patent/CA2965472C/en active Active
- 2015-03-19 KR KR1020207019853A patent/KR20200087273A/ko not_active Ceased
- 2015-03-19 DK DK15714352.0T patent/DK3209655T3/da active
- 2015-03-19 PT PT157143520T patent/PT3209655T/pt unknown
- 2015-03-19 RS RS20201226A patent/RS61013B1/sr unknown
- 2015-03-19 RU RU2019110152A patent/RU2741576C2/ru active
- 2015-03-19 CN CN201580070262.8A patent/CN107108573B/zh active Active
- 2015-03-19 AU AU2015337091A patent/AU2015337091B2/en active Active
- 2015-03-19 WO PCT/US2015/021417 patent/WO2016064445A1/en not_active Ceased
- 2015-03-19 SI SI201531382T patent/SI3209655T1/sl unknown
- 2015-03-19 BR BR112017008416-3A patent/BR112017008416B1/pt active IP Right Grant
- 2015-03-19 LT LTEP15714352.0T patent/LT3209655T/lt unknown
- 2015-03-19 US US14/662,506 patent/US9556146B2/en active Active
- 2015-03-19 EP EP15714352.0A patent/EP3209655B1/en active Active
- 2015-03-19 KR KR1020177014045A patent/KR102026342B1/ko active Active
- 2015-03-19 EP EP20178083.0A patent/EP3757099B1/en active Active
- 2015-03-19 HR HRP20201416TT patent/HRP20201416T1/hr unknown
- 2015-03-19 KR KR1020197027820A patent/KR102134171B1/ko active Active
- 2015-03-19 ES ES15714352T patent/ES2822987T3/es active Active
-
2016
- 2016-12-09 US US15/374,556 patent/US9839635B2/en active Active
-
2017
- 2017-06-01 IL IL252630A patent/IL252630B/en active IP Right Grant
- 2017-10-27 US US15/795,906 patent/US10028950B2/en active Active
-
2018
- 2018-06-13 US US16/007,151 patent/US10201538B2/en active Active
- 2018-12-20 US US16/227,940 patent/US10493072B2/en active Active
-
2019
- 2019-02-21 AU AU2019201231A patent/AU2019201231A1/en not_active Abandoned
- 2019-03-14 JP JP2019046867A patent/JP6806829B2/ja active Active
- 2019-10-15 US US16/653,446 patent/US10682349B2/en active Active
-
2020
- 2020-05-04 US US16/866,169 patent/US10849895B2/en active Active
- 2020-06-05 IL IL275155A patent/IL275155B/en active IP Right Grant
- 2020-10-15 RU RU2020133839A patent/RU2768888C1/ru active
- 2020-10-20 US US17/075,199 patent/US11571419B2/en active Active
- 2020-12-04 JP JP2020201503A patent/JP2021073170A/ja active Pending
-
2021
- 2021-03-04 AU AU2021201405A patent/AU2021201405B2/en active Active
-
2022
- 2022-12-20 US US18/085,018 patent/US20230142910A1/en active Pending